BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $427 | +102.4% | 9,993 | +83.3% | 0.01% | +100.0% |
Q4 2023 | $211 | -87.5% | 5,452 | -87.8% | 0.00% | -89.7% |
Q3 2023 | $1,685 | +151.5% | 44,658 | +203.5% | 0.04% | +143.8% |
Q2 2023 | $670 | +87.7% | 14,714 | +67.1% | 0.02% | +77.8% |
Q1 2023 | $357 | -51.2% | 8,806 | -38.6% | 0.01% | -52.6% |
Q4 2022 | $731 | -99.9% | 14,339 | +38.3% | 0.02% | -32.1% |
Q3 2022 | $558,000 | -26.9% | 10,367 | -12.7% | 0.03% | -15.2% |
Q2 2022 | $763,000 | +11.2% | 11,873 | +34.2% | 0.03% | +26.9% |
Q1 2022 | $686,000 | +72.8% | 8,849 | +91.3% | 0.03% | +73.3% |
Q4 2021 | $397,000 | +6.7% | 4,626 | 0.0% | 0.02% | +7.1% |
Q3 2021 | $372,000 | 0.0% | 4,626 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $372,000 | -4.6% | 4,626 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $390,000 | +5.1% | 4,626 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $371,000 | -32.8% | 4,626 | -32.6% | 0.02% | -36.0% |
Q3 2020 | $552,000 | +38.7% | 6,862 | +48.3% | 0.02% | +25.0% |
Q2 2020 | $398,000 | -68.9% | 4,626 | -69.8% | 0.02% | -66.7% |
Q4 2019 | $1,279,000 | +324.9% | 15,297 | +344.2% | 0.06% | +300.0% |
Q3 2019 | $301,000 | +2.4% | 3,444 | -4.2% | 0.02% | +7.1% |
Q2 2019 | $294,000 | – | 3,595 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |